Drug recall · December 17, 2014
CYANOCOBALAMIN INJECTION recall
Why: Lack of Assurance of Sterility: Glass vials may have finish fractures and glass particles.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
CYANOCOBALAMIN INJECTION, USP, 1000 mcg/mL, For IM or IV Use, Multiple Dose 2 mL Vials, Rx only. APP Pharmaceuticals, LLC, Schaumburg, IL 60173. NDC: 63323-044-01.
- Lots / codes
Lot 6003853, exp. date 04/2014
- Quantity
- 240,550 Vials
- Company
- Fresenius Kabi USA, LLC, Lake Zurich, IL
- Distribution
- U.S. Nationwide Including Puerto Rico
- Initiated
- September 27, 2012 · Voluntary: Firm initiated
- Classified
- December 10, 2014
- Reported
- December 17, 2014
- Ended
- December 12, 2014
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Vitamin B12
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.